$1.73
4.42% yesterday
NYSE, Jun 13, 10:16 pm CET
ISIN
US67080N1019
Symbol
NUVB
Sector
Industry

Nuvation Bio Inc - Ordinary Shares - Class A Target price 2025 - Analyst rating & recommendation

Nuvation Bio Inc - Ordinary Shares - Class A Classifications & Recommendation:

Buy
100%

Nuvation Bio Inc - Ordinary Shares - Class A Price Target

Target Price $8.43
Price $1.73
Potential
Number of Estimates 7
7 Analysts have issued a price target Nuvation Bio Inc - Ordinary Shares - Class A 2026 . The average Nuvation Bio Inc - Ordinary Shares - Class A target price is $8.43. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 8 analysts: 8 Analysts recommend Nuvation Bio Inc - Ordinary Shares - Class A to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Nuvation Bio Inc - Ordinary Shares - Class A stock has an average upside potential 2026 of . Most analysts recommend the Nuvation Bio Inc - Ordinary Shares - Class A stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 7.87 14.51
84.43%
Net Margin -7,216.52% -1,576.76%
78.15%

8 Analysts have issued a sales forecast Nuvation Bio Inc - Ordinary Shares - Class A 2025 . The average Nuvation Bio Inc - Ordinary Shares - Class A sales estimate is

$14.5m
Unlock
. This is
32.43% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$22.0m 100.73%
Unlock
, the lowest is
$6.0m 44.93%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $7.9m
2025
$14.5m 84.43%
Unlock
2026
$72.5m 399.67%
Unlock
2027
$141m 94.22%
Unlock
2028
$280m 98.61%
Unlock
2029
$517m 84.85%
Unlock

5 Nuvation Bio Inc - Ordinary Shares - Class A Analysts have issued a net profit forecast 2025. The average Nuvation Bio Inc - Ordinary Shares - Class A net profit estimate is

$-229m
Unlock
. This is
62.26% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-224m 63.01%
Unlock
, the lowest is
$-234m 61.49%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-568m 649.26%
2025
$-229m 59.70%
Unlock
2026
$-244m 6.44%
Unlock
2027
$-195m 19.78%
Unlock
2028
$-128m 34.35%
Unlock
2029
$229m 278.14%
Unlock

Net Margin

2024 -7,216.52%
2025
-1,576.76% 78.15%
Unlock
2026
-335.88% 78.70%
Unlock
2027
-138.72% 58.70%
Unlock
2028
-45.86% 66.94%
Unlock
2029
44.19% 196.36%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -2.11 -0.67
502.86% 68.25%
P/E negative
EV/Sales 9.14

5 Analysts have issued a Nuvation Bio Inc - Ordinary Shares - Class A forecast for earnings per share. The average Nuvation Bio Inc - Ordinary Shares - Class A EPS is

$-0.67
Unlock
. This is
62.57% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-0.66 63.13%
Unlock
, the lowest is
$-0.69 61.45%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-2.11 502.86%
2025
$-0.67 68.25%
Unlock
2026
$-0.72 7.46%
Unlock
2027
$-0.58 19.44%
Unlock
2028
$-0.38 34.48%
Unlock
2029
$0.67 276.32%
Unlock

P/E ratio

Current -0.97 89.18%
2025
-2.57 165.91%
Unlock
2026
-2.41 6.23%
Unlock
2027
-3.01 24.90%
Unlock
2028
-4.58 52.16%
Unlock
2029
2.57 156.11%
Unlock

Based on analysts' sales estimates for 2025, the Nuvation Bio Inc - Ordinary Shares - Class A stock is valued at an EV/Sales of

and an P/S ratio of
40.56
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 12.10
2025
9.14 24.47%
Unlock
2026
1.83 79.99%
Unlock
2027
0.94 48.51%
Unlock
2028
0.47 49.65%
Unlock
2029
0.26 45.91%
Unlock

P/S ratio

Current
2025
40.56 24.49%
Unlock
2026
8.12 79.99%
Unlock
2027
4.18 48.51%
Unlock
2028
2.10 49.65%
Unlock
2029
1.14 45.90%
Unlock

Current Nuvation Bio Inc - Ordinary Shares - Class A Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Wedbush
Locked
Locked
Locked Jun 11 2025
JMP Securities
Locked
Locked
Locked Jun 02 2025
Wedbush
Locked
Locked
Locked May 16 2025
JMP Securities
Locked
Locked
Locked Apr 23 2025
Jones Trading
Locked
Locked
Locked Mar 12 2025
HC Wainwright & Co.
Locked
Locked
Locked Mar 10 2025
HC Wainwright & Co.
Locked
Locked
Locked Jan 23 2025
Analyst Rating Date
Locked
Wedbush:
Locked
Locked
Jun 11 2025
Locked
JMP Securities:
Locked
Locked
Jun 02 2025
Locked
Wedbush:
Locked
Locked
May 16 2025
Locked
JMP Securities:
Locked
Locked
Apr 23 2025
Locked
Jones Trading:
Locked
Locked
Mar 12 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Mar 10 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Jan 23 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today